»áÕ¹Ãû³Æ | 2011Ä꺺Ãܶû¶ÙӲƤ²¡¸üлáÒ飨HSU£© |
²¼Õ¹Ê±¼ä | 2011Äê9ÔÂ23ÈÕ |
Õ¹ÀÀʱ¼ä | 2011Äê9ÔÂ24ÈÕ |
³·Õ¹Ê±¼ä | 2011Äê9ÔÂ25ÈÕ |
ËùÔÚµØÖ· |
¼ÓÄôó ¹þÃܶû¶Ù |
»áÕ¹³¡¹Ý | ¹þÃܶû¶Ù»áÒéÖÐÐÄ |
²Î»á×¢²á·Ñ | ¿ÉÒÔ. »áÔ±/·Ç»áÔ± ·þÎñ·Ñ300ÈËÃñ±Ò/ÈË |
´úËÍǩ֤ | ¿ÉÒÔ. ·þÎñ·Ñ500ÈËÃñ±Ò/ÈË |
´ú¶©»úƱ | ¿ÉÒÔ. ÇëÓë¿Í·þÈËÔ±ÁªÏµ |
´ú¶¨Õ¹Î» |
²»¿ÉÒÔ |
´ú¶¨¾Æµê |
¿ÉÒÔ. ·þÎñ·ÑΪ×Ü·ÑÓÃ15% |
»áÕ¹ÃèÊö |
The event has been designed as a one day learning experience for both scleroderma patients and healthcare professionals. It will feature current evidence and best practice information regarding early diagnosis, ongoing disease monitoring and recognition of important medical warning signs, treatment options and management strategies to provide guidance for patients and healthcare professionals. The goal is that better management of scleroderma as a multi-spectrum, chronic disease will be achieved. ʼþÒѱ»Éè¼Æ³ÉÓÐÒ»ÌìµÄѧϰ¾ÑéΪӲƤ²¡»¼ÕߺÍÒ½»¤ÈËÔ±¡£Ëü½«¹¦ÄÜ£¬ÏÖÓеÄÖ¤¾ÝºÍ×î¼Ñʵ¼ùÐÅÏ¢£¬¶ÔÔçÆÚÕï¶Ï£¬³ÖÐøµÄ¼²²¡¼à²âºÍÖØÒªµÄÒ½Áƾ¯¸æ±êÖ¾£¬ÖÎÁÆ·½°¸ºÍ¹ÜÀí²ßÂÔµÄÈÏͬ£¬Îª²¡È˺ÍÒ½»¤ÈËÔ±µÄÖ¸µ¼¡£ÎÒÃǵÄÄ¿±êÊǸüºÃµØ¹ÜÀí×÷Ϊһ¸ö¶à¹âÆ×£¬Ó²Æ¤²¡£¬ÂýÐÔ¼²²¡½«µÃÒÔʵÏÖ¡£ |
Õ¹»áÖÜÆÚ |
ÿÄêÒ»½ì¡¡ |
×¢ÒâÊÂÏî |
1.ÒÔÉϱê×¢"¿ÉÒÔ"µÄ·þÎñÏîÄ¿¿Éµ¥¶À°ìÀí. |
ÔÚÏß×Éѯ | |
ÓÑÇéÌáʾ |
»ãÂʼÆËãÒÔ¸¶¿îʱÖйú¹¤ÉÌÒøÐÐÍâ»ãÂô³ö¼ÛΪ׼. |
ÁªÏµ·½Ê½ |
×Éѯµç»°: 8610-66054455 8610-51294800 ÉèËߵ绰: 8610-66054488 |